ATG7 Antibodies

Santa Cruz Biotechnology provides a broad selection of ATG7 monoclonal antibodies for research in autophagy and cellular homeostasis. ATG7 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ATG7, or autophagy-related protein 7, plays a crucial role in the autophagy process, facilitating the formation of autophagosomes and the degradation of cellular components. ATG7 is essential for maintaining cellular health and has been implicated in various diseases, including cancer and neurodegenerative disorders. Understanding ATG7 function is vital for elucidating the mechanisms of autophagy and its impact on disease progression. Researchers can utilize ATG7 monoclonal antibodies to investigate cellular degradation pathways and their regulation. ATG7 monoclonal antibodies enable detailed examination of autophagy mechanisms in various experimental models. The high specificity of ATG7 monoclonal antibodies supports reliable detection and characterization of autophagy processes. Santa Cruz Biotechnology monoclonal antibodies for ATG7 contribute to advancing scientific understanding of cellular quality control and disease mechanisms.